Inhibitory effects of meju prepared with mixed starter cultures on azoxymethane and dextran sulfate sodium-induced colon carcinogenesis in mice

Journal of Carcinogenesis

Volumn 11, Issue , 2012, Pages

  Jeong, Ji Kang ^a   Chang, Hee Kyung ^b   Park, Kun Young ^a  

^a Pusan National University   (South Korea)

^b Kosin University   (South Korea)

Author keywords

Colon carcinogenesis; Inflammation; Meju; starter culture

Indexed keywords

AZOXYMETHANE; CYCLOOXYGENASE 2; DEXTRAN SULFATE; INDUCIBLE NITRIC OXIDE SYNTHASE; MEJU; PROBIOTIC AGENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASPERGILLUS ORYZAE; BACILLUS SUBTILIS; BODY WEIGHT; CANCER INHIBITION; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; ORGAN WEIGHT; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STARTER CULTURE;

EID: 84872690217     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.100404     Document Type: Article

References (33)

1. Jung KO, Park SY, Park KY. Longer aging time increases the anticancer and antimetastatic properties of deonjang. Nutrition 2006;22:539-45.
2. Park KY, Jung KO, Rhee SH, Choi YH. Antimutagenic effects of doenjang (Korean fermented soypaste) and its active compounds. Mutat Res 2003;523-524:43-53. (Pubitemid 36293231)
3. Im MH, Choi JD, Chung HC, Lee SH, Lee CW, Choi C, et al. Improvement of meju preparation method for the production of Korean traditional kanjang (say sauce). Korean J Food Sci Technol 1998;30:608-14.
4. Kim YS, Park CW, Kim SJ, Park SJ, Ryu CH, Cho HJ, et al. Preparation of mushroom mycelia-cultured traditional meju with enhanced anticarcinogenecity and sensory quality. J Korean Soc Food Sci Nutr 2002;31:986-93.
5. Kim DH, Lee KH, Yook HS, Kim JH, Shin MG, Byun MW. Quality characteristics of gamma irradiated grain shape improved meju. Korean J Food Sci Technol 2000;32:640-45.
6. Ko BK, Kim KM, Hong YS, Lee CH. Metabolic assessment of fermentative capability of soybean starter treated with high pressure. J Agric Food Chem 2010;58:8738-47.
7. Park KY, Jung KO. Fermented soybean products as functional foods: Functional properties of doenjang (fermented soybean paste). In: John S, editor. Asian functional foods. FL, USA: CRC; 2005. p. 555-96.
8. Choi KS, Lee HJ, Kwon DJ. Physicochemical and microbiological properties of Korean traditional Meju. Korean J Food Preserv 2009;16:217-22.
9. Janakiram NB, Rao CV. Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol Sol 2008;29:1-20.
10. Benson AB 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm 2007;13:5-18.
11. Manasa K, Mari MK, Emiko M. Animal models of colitis-associated carcinogenesis. J Biomed Biotechnol 2011; Article ID 342637.
12. Muller-Decker K, Furstenberger G. The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis. Mol Carcinog 2007;46:705-10. (Pubitemid 47255191)
13. Kawanishi S, Hikaru Y, Pinlaor S, Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory disease in relation to inflammation-related carcinogenesis. Bio Chem 2006;387:365-72.
14. Danuta MG, Natalia T. Molecular mechanisms of carcinogenesis. In: Wanda BD, editor. Carcinogenesis and anticarcinogenic food components. FL, USA: CRC; 2006. p. 13-36.
15. Jeong JK. Improvement of quality and probiotic effect of meju and doenjang prepared with mixed starter cultures Doctoral Thesis . Busan, Korea: Pusan National University; 2012. p. 111-125
16. Melgar S, Karlsson L, Rehnstrom E, Karlsson A, Utkovic H, Jansson L, et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int immunopharmacol 2008;8:836-44.
17. Villegas I, Snchez-Fidalgo S, de la Lastra CA Chemopreventive effect of dietary curcumin on inflammation-induced colorectal carcinogenesis in mice. Mol Nutr Food Res 2011;55:259-67.
18. Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J. Inhibition of NAD(P) H: Quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci USA 2005;102:5535-40. (Pubitemid 40530293)
19. Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 2003;100:14-8.
20. Li H, Wu KK, Li ZJ, Chan KM, Wong CM, Ye CG, et al. 2,3,4,4,5- pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice. Br J Pharmacol 2010;160:1352-61.
21. Tanaka T, Kohno H, Murakami M, Shimada R, Kagami S. Colitis-related rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methyazoxymethanol acetate. Oncol Rep 2000;7:501-8.
22. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: Studies in human and animal models. Carcinogenesis 2003;24:353-62. (Pubitemid 36432628)
23. Kohno H, Suzuki R, Curini M, Epifano F, Maltese F, Gonzales SP, et al. Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice. Int J Cancer 2006;118:2936-42.
24. Fantini MC, Pallone F. Cytokines: From gut inflammation to colorectal cancer. Curr Drug Targets 2008;9:375-80. (Pubitemid 352025211)
25. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003;94:965-73. (Pubitemid 37508979)
26. Tanaka K. Colorectal carcinogenesis: Review of human and experimental animal studies. J Carcinog 2009;8:5.
27. Popivaniva BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S. Blocking TNF-in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118:560-70. (Pubitemid 351206546)
28. Suh N, Paul S, Hao X, Simi B, Xiao H, Rimando AM, et al. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clin Cancer Res 2007;13:350-5. (Pubitemid 46121889)
29. McKenzie SJ, Baker MS, Buffinton GD, Doe WF. Evidence of oxidant-induced injury to epithelial cell during inflammatory bowel disease. J Clin Invest 1996;98:136-41. (Pubitemid 26243829)
30. Kim SJ, Kim KW, Kim DS, Kim MC, Jeon YD, Kim SG, et al. The protective effect of Cassia obtusifolia on DSS-induced colitis. Am J Chin Med 2011;39:565-77.
31. Jaiswal M, LaRusso NF, Gores GJ. Nitric oxide in gastrointestinal epithelial cell carcinogenesis, linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 2001;281:G626-34.
32. Lin HY, Sun M, Tang HY, Simone TM, Wu YH, Grandis JR, et al. Resveratrol causes COX-2-and p53-dependent apoptosis in head and neck squamous cell cancer cells. J Cell Biochem 2008;104:2131-42.
33. Liontas A, Yeger H. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 2004;24:987-98. (Pubitemid 38625049)